Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier.

Garber JJ, Mallick EM, Scanlon KM, Turner JR, Donnenberg MS, Leong JM, Snapper SB.

Cell Mol Gastroenterol Hepatol. 2017 Dec 15;5(3):273-288. doi: 10.1016/j.jcmgh.2017.11.015. eCollection 2018 Mar.

2.

Genomic diversity of EPEC associated with clinical presentations of differing severity.

Hazen TH, Donnenberg MS, Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng JB, Ramamurthy T, Tamboura B, Qureshi S, Quadri F, Zaidi A, Kotloff KL, Levine MM, Barry EM, Kaper JB, Rasko DA, Nataro JP.

Nat Microbiol. 2016 Jan 18;1:15014. doi: 10.1038/nmicrobiol.2015.14.

3.

Pilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute Clostridium difficile Infection.

Maldarelli GA, Matz H, Gao S, Chen K, Hamza T, Yfantis HG, Feng H, Donnenberg MS.

J Vaccines Vaccin. 2016;7(3). pii: 321. Epub 2016 May 27.

4.

Type IV pili promote early biofilm formation by Clostridium difficile.

Maldarelli GA, Piepenbrink KH, Scott AJ, Freiberg JA, Song Y, Achermann Y, Ernst RK, Shirtliff ME, Sundberg EJ, Donnenberg MS, von Rosenvinge EC.

Pathog Dis. 2016 Aug;74(6). pii: ftw061. doi: 10.1093/femspd/ftw061. Epub 2016 Jun 30.

5.

BfpI, BfpJ, and BfpK Minor Pilins Are Important for the Function and Biogenesis of Bundle-Forming Pili Expressed by Enteropathogenic Escherichia coli.

Martinez de la Peña CF, De Masi L, Nisa S, Mulvey G, Tong J, Donnenberg MS, Armstrong GD.

J Bacteriol. 2015 Dec 28;198(5):846-56. doi: 10.1128/JB.00818-15.

6.

Diarrhea, bacteremia and multiorgan dysfunction due to an extraintestinal pathogenic Escherichia coli strain with enteropathogenic E. coli genes.

Kessler R, Nisa S, Hazen TH, Horneman A, Amoroso A, Rasko DA, Donnenberg MS.

Pathog Dis. 2015 Nov;73(8):ftv076. doi: 10.1093/femspd/ftv076. Epub 2015 Sep 26.

7.

Bacterial Factors Associated with Lethal Outcome of Enteropathogenic Escherichia coli Infection: Genomic Case-Control Studies.

Donnenberg MS, Hazen TH, Farag TH, Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng JB, Ramamurthy T, Tamboura B, Zaidi A, Levine MM, Kotloff K, Rasko DA, Nataro JP.

PLoS Negl Trop Dis. 2015 May 15;9(5):e0003791. doi: 10.1371/journal.pntd.0003791. eCollection 2015 May.

8.

Type IV pilus secretins have extracellular C termini.

Lieberman JA, Petro CD, Thomas S, Yang A, Donnenberg MS.

MBio. 2015 Mar 24;6(2). pii: e00322-15. doi: 10.1128/mBio.00322-15.

9.

Signature-tagged mutagenesis and co-infection studies demonstrate the importance of P fimbriae in a murine model of urinary tract infection.

Buckles EL, Luterbach CL, Wang X, Lockatell CV, Johnson DE, Mobley HL, Donnenberg MS.

Pathog Dis. 2015 Jun;73(4). pii: ftv014. doi: 10.1093/femspd/ftv014. Epub 2015 Feb 11.

10.

Structural and evolutionary analyses show unique stabilization strategies in the type IV pili of Clostridium difficile.

Piepenbrink KH, Maldarelli GA, Martinez de la Peña CF, Dingle TC, Mulvey GL, Lee A, von Rosenvinge E, Armstrong GD, Donnenberg MS, Sundberg EJ.

Structure. 2015 Feb 3;23(2):385-96. doi: 10.1016/j.str.2014.11.018. Epub 2015 Jan 15.

11.

Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.

Long TM, Nisa S, Donnenberg MS, Hassel BA.

Infect Immun. 2014 Jul;82(7):2802-14. doi: 10.1128/IAI.00105-14. Epub 2014 Apr 14.

12.

Identification, immunogenicity, and cross-reactivity of type IV pilin and pilin-like proteins from Clostridium difficile.

Maldarelli GA, De Masi L, von Rosenvinge EC, Carter M, Donnenberg MS.

Pathog Dis. 2014 Aug;71(3):302-14. doi: 10.1111/2049-632X.12137. Epub 2014 Feb 18.

13.

Structure of Clostridium difficile PilJ exhibits unprecedented divergence from known type IV pilins.

Piepenbrink KH, Maldarelli GA, de la Peña CF, Mulvey GL, Snyder GA, De Masi L, von Rosenvinge EC, Günther S, Armstrong GD, Donnenberg MS, Sundberg EJ.

J Biol Chem. 2014 Feb 14;289(7):4334-45. doi: 10.1074/jbc.M113.534404. Epub 2013 Dec 21.

14.

Uncomplicated cystitis--not so simple.

Donnenberg MS.

N Engl J Med. 2013 Nov 14;369(20):1959-60. doi: 10.1056/NEJMe1312412. No abstract available.

PMID:
24224629
15.

How to diagnose a foodborne illness.

Donnenberg MS, Narayanan S.

Infect Dis Clin North Am. 2013 Sep;27(3):535-54. doi: 10.1016/j.idc.2013.05.001. Epub 2013 Aug 8. Review.

PMID:
24011829
16.

In vitro evolution of an archetypal enteropathogenic Escherichia coli strain.

Nisa S, Hazen TH, Assatourian L, Nougayrède JP, Rasko DA, Donnenberg MS.

J Bacteriol. 2013 Oct;195(19):4476-83. doi: 10.1128/JB.00704-13. Epub 2013 Aug 2.

17.

Draft Genome Sequences of Three O157 Enteropathogenic Escherichia coli Isolates.

Hazen TH, Sahl JW, Fraser CM, Donnenberg MS, Scheutz F, Rasko DA.

Genome Announc. 2013 Jul 18;1(4). pii: e00516-13. doi: 10.1128/genomeA.00516-13.

18.

Refining the pathovar paradigm via phylogenomics of the attaching and effacing Escherichia coli.

Hazen TH, Sahl JW, Fraser CM, Donnenberg MS, Scheutz F, Rasko DA.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12810-5. doi: 10.1073/pnas.1306836110. Epub 2013 Jul 15.

19.

Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward.

Donnenberg MS, Finlay BB.

Trends Microbiol. 2013 Jul;21(7):317-9. doi: 10.1016/j.tim.2013.05.003.

20.

An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins.

Maddocks OD, Scanlon KM, Donnenberg MS.

MBio. 2013 Jun 18;4(3):e00152-13. doi: 10.1128/mBio.00152-13.

21.

The E. coli effector protein NleF is a caspase inhibitor.

Blasche S, Mörtl M, Steuber H, Siszler G, Nisa S, Schwarz F, Lavrik I, Gronewold TM, Maskos K, Donnenberg MS, Ullmann D, Uetz P, Kögl M.

PLoS One. 2013;8(3):e58937. doi: 10.1371/journal.pone.0058937. Epub 2013 Mar 14.

22.

BfpL is essential for type IV bundle-forming pilus biogenesis and interacts with the periplasmic face of BfpC.

De Masi L, Szmacinski H, Schreiber W, Donnenberg MS.

Microbiology. 2012 Oct;158(Pt 10):2515-26. Epub 2012 Jul 26.

23.

Retraction of enteropathogenic E. coli type IV pili promotes efficient host cell colonization, effector translocation and tight junction disruption.

Aroeti B, Friedman G, Zlotkin-Rivkin E, Donnenberg MS.

Gut Microbes. 2012 May-Jun;3(3):267-71. doi: 10.4161/gmic.19814. Epub 2012 May 1. Review.

24.

Structure of an essential type IV pilus biogenesis protein provides insights into pilus and type II secretion systems.

Yamagata A, Milgotina E, Scanlon K, Craig L, Tainer JA, Donnenberg MS.

J Mol Biol. 2012 May 25;419(1-2):110-24. doi: 10.1016/j.jmb.2012.02.041. Epub 2012 Mar 1.

25.

Outer membrane targeting, ultrastructure, and single molecule localization of the enteropathogenic Escherichia coli type IV pilus secretin BfpB.

Lieberman JA, Frost NA, Hoppert M, Fernandes PJ, Vogt SL, Raivio TL, Blanpied TA, Donnenberg MS.

J Bacteriol. 2012 Apr;194(7):1646-58. doi: 10.1128/JB.06330-11. Epub 2012 Jan 13.

26.

The inner membrane subassembly of the enteropathogenic Escherichia coli bundle-forming pilus machine.

Milgotina EI, Lieberman JA, Donnenberg MS.

Mol Microbiol. 2011 Aug;81(4):1125-7. No abstract available.

PMID:
21977501
27.

The N-terminal amphipathic region of the Escherichia coli type III secretion system protein EspD is required for membrane insertion and function.

Dasanayake D, Richaud M, Cyr N, Caballero-Franco C, Pittroff S, Finn RM, Ausió J, Luo W, Donnenberg MS, Jardim A.

Mol Microbiol. 2011 Aug;81(3):734-50. doi: 10.1111/j.1365-2958.2011.07727.x. Epub 2011 Jun 28.

28.

Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivity.

Zahavi EE, Lieberman JA, Donnenberg MS, Nitzan M, Baruch K, Rosenshine I, Turner JR, Melamed-Book N, Feinstein N, Zlotkin-Rivkin E, Aroeti B.

Mol Biol Cell. 2011 Jul 15;22(14):2436-47. doi: 10.1091/mbc.E11-01-0001. Epub 2011 May 25.

29.

Interactions and predicted host membrane topology of the enteropathogenic Escherichia coli translocator protein EspB.

Luo W, Donnenberg MS.

J Bacteriol. 2011 Jun;193(12):2972-80. doi: 10.1128/JB.00153-11. Epub 2011 Apr 15.

30.

N-acetyllactosamine-induced retraction of bundle-forming pili regulates virulence-associated gene expression in enteropathogenic Escherichia coli.

Humphries RM, Griener TP, Vogt SL, Mulvey GL, Raivio T, Donnenberg MS, Kitov PI, Surette M, Armstrong GD.

Mol Microbiol. 2010 Jun 1;76(5):1111-26. doi: 10.1111/j.1365-2958.2010.07192.x. Epub 2010 May 4.

31.

The Cpx envelope stress response both facilitates and inhibits elaboration of the enteropathogenic Escherichia coli bundle-forming pilus.

Vogt SL, Nevesinjac AZ, Humphries RM, Donnenberg MS, Armstrong GD, Raivio TL.

Mol Microbiol. 2010 Jun 1;76(5):1095-110. doi: 10.1111/j.1365-2958.2010.07145.x. Epub 2010 Apr 14.

32.

Allelic variability of critical virulence genes (eae, bfpA and perA) in typical and atypical enteropathogenic Escherichia coli in Peruvian children.

Contreras CA, Ochoa TJ, Lacher DW, DebRoy C, Navarro A, Talledo M, Donnenberg MS, Ecker L, Gil AI, Lanata CF, Cleary TG.

J Med Microbiol. 2010 Jan;59(Pt 1):25-31. doi: 10.1099/jmm.0.013706-0.

33.

A novel approach to investigate the uptake and internalization of Escherichia coli O157:H7 in spinach cultivated in soil and hydroponic medium.

Sharma M, Ingram DT, Patel JR, Millner PD, Wang X, Hull AE, Donnenberg MS.

J Food Prot. 2009 Jul;72(7):1513-20.

PMID:
19681280
34.

Uropathogenic Escherichia coli.

Mobley HL, Donnenberg MS, Hagan EC.

EcoSal Plus. 2009 Aug;3(2). doi: 10.1128/ecosalplus.8.6.1.3.

PMID:
26443763
35.

Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans.

Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ.

PLoS One. 2009;4(5):e5517. doi: 10.1371/journal.pone.0005517. Epub 2009 May 13.

36.

Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance.

Buckles EL, Wang X, Lane MC, Lockatell CV, Johnson DE, Rasko DA, Mobley HL, Donnenberg MS.

J Infect Dis. 2009 Jun 1;199(11):1689-97. doi: 10.1086/598524.

37.

From alpha to beta: identification of amino acids required for the N-acetyllactosamine-specific lectin-like activity of bundlin.

Humphries RM, Donnenberg MS, Strecker J, Kitova E, Klassen JS, Cui L, Griener TP, Mulvey GL, Armstrong GD.

Mol Microbiol. 2009 May;72(4):859-68. doi: 10.1111/j.1365-2958.2009.06679.x. Epub 2009 Apr 14.

38.

Rapid site-directed domain scanning mutagenesis of enteropathogenic Escherichia coli espD.

Deng Q, Luo W, Donnenberg MS.

Biol Proced Online. 2007 Sep 14;9:18-26. doi: 10.1251/bpo130.

39.

Encephalitis of the basal ganglia in an injection drug user.

Carpenter M, Polk C, Castellani R, Mochoruk K, Sanche S, Stern B, Donnenberg MS.

Clin Infect Dis. 2007 Dec 1;45(11):1479, 1522-4. No abstract available.

PMID:
17990237
40.

The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin.

Hyland RM, Sun J, Griener TP, Mulvey GL, Klassen JS, Donnenberg MS, Armstrong GD.

Cell Microbiol. 2008 Jan;10(1):177-87. Epub 2007 Aug 14.

41.

Functional consequences of sequence variation in bundlin, the enteropathogenic Escherichia coli type IV pilin protein.

Fernandes PJ, Guo Q, Donnenberg MS.

Infect Immun. 2007 Oct;75(10):4687-96. Epub 2007 Jul 16.

42.

The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model.

Fernandes PJ, Guo Q, Waag DM, Donnenberg MS.

Infect Immun. 2007 Jun;75(6):3027-32. Epub 2007 Apr 2.

43.

Molecular evolution of typical enteropathogenic Escherichia coli: clonal analysis by multilocus sequence typing and virulence gene allelic profiling.

Lacher DW, Steinsland H, Blank TE, Donnenberg MS, Whittam TS.

J Bacteriol. 2007 Jan;189(2):342-50. Epub 2006 Nov 10.

44.

Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2.

Nougayrède JP, Foster GH, Donnenberg MS.

Cell Microbiol. 2007 Mar;9(3):680-93. Epub 2006 Oct 25.

PMID:
17064289
45.

Interaction and localization studies of enteropathogenic Escherichia coli type IV bundle-forming pilus outer membrane components.

Daniel A, Singh A, Crowther LJ, Fernandes PJ, Schreiber W, Donnenberg MS.

Microbiology. 2006 Aug;152(Pt 8):2405-20.

PMID:
16849804
46.
47.

PhoU enhances the ability of extraintestinal pathogenic Escherichia coli strain CFT073 to colonize the murine urinary tract.

Buckles EL, Wang X, Lockatell CV, Johnson DE, Donnenberg MS.

Microbiology. 2006 Jan;152(Pt 1):153-60.

PMID:
16385125
48.

Structure of the bundle-forming pilus from enteropathogenic Escherichia coli.

Ramboarina S, Fernandes PJ, Daniell S, Islam S, Simpson P, Frankel G, Booy F, Donnenberg MS, Matthews S.

J Biol Chem. 2005 Dec 2;280(48):40252-60. Epub 2005 Sep 19.

49.

The ATPase activity of BfpD is greatly enhanced by zinc and allosteric interactions with other Bfp proteins.

Crowther LJ, Yamagata A, Craig L, Tainer JA, Donnenberg MS.

J Biol Chem. 2005 Jul 1;280(26):24839-48. Epub 2005 May 2. Retraction in: J Biol Chem. 2009 Jul 31;284(31):21100.

50.

Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.

Klapproth JM, Sasaki M, Sherman M, Babbin B, Donnenberg MS, Fernandes PJ, Scaletsky IC, Kalman D, Nusrat A, Williams IR.

Infect Immun. 2005 Mar;73(3):1441-51. Erratum in: Infect Immun. 2005 May;73(5):3196.

Supplemental Content

Loading ...
Support Center